Wikipedia -WSS

Wikipedia

author：leisure time 2025-09-30 18:20:54 - browse：4

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Today, we explore the future of obesity drugs and how they’re named, we chat with CRISPR pioneers about what it’s like to see the technology approved for human use, and more.

The need-to-know this morning:
• Bayer said it prematurely stopped a Phase 3 study in stroke prevention after independent monitors concluded its experimental blood-thinning medicine, called asundexian, showed inferior efficacy compared to a standard treatment. The asundexian study setback is a significant blow to Bayer’s effort to revamp its drug-development pipeline, analysts said.
• Carmot Therapeutics filed paperwork Friday for an initial public offering of undisclosed size. The Berkeley, Calif.-based company is developing drugs that target GLP-1 and GIP to treat diabetes and obesity, similar to Novo Nordisk’s Ozempic/Wegovy and Eli Lilly’s Mounjaro/Zepbound.
• Bristol Myers Squibb and 2Seventy Bio said the FDA will not complete an on-time review of its application seeking to expand the use of Abecma, their CAR-T therapy for multiple myeloma. Instead, the FDA will convene an advisory panel meeting — date to be determined — to examine survival data from an Abecma clinical trial.
• The U.K. and the pharmaceutical industry have reached a deal on a five-year plan outlining how the health system pays for drugs, as the country tries to keep a lid on its medicines spending while simultaneously building up its life sciences industry. STAT’s Andrew Joseph has more here.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Flash flood warnings continue for parts of Missouri, Illinois

explore

leisure time

WSS

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

RSV vaccines may be linked to small increased risk of developing GBS

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

How CRISPR works, explained in two minutes

House looks to weaken Medicare negotiation

RSV vaccines may be linked to small increased risk of developing GBS

hotspot

Wikipedia

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

Medical device lobby: We're tired of waiting on Medicare coverage

How one medical school became remarkably diverse

AstraZeneca loses challenge to Medicare drug price negotiation

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

RaDonda Vaught to speak at CommonSpirit event on patient safety

After affirmative action ruling, medical educators look to 'holistic review'

Restaurant meals are packed with calories, and we still keep eating them

Hepatitis C has a cure — but many Americans still lack access to it

International team creates first chimeric human

Wikipedia

Flash flood warnings continue for parts of Missouri, Illinois

Restaurant meals are packed with calories, and we still keep eating them

Election results set back Medicaid expansion plans

Change Healthcare cyberattack outage could last weeks

Change Healthcare cyberattack outage could last weeks

Why getting cancer drugs just got harder for rural patients

explore

leisure time

knowledge

hotspot